Chemistry:Synapsinostat
From HandWiki
Synapsinostat, also known as CN13, is a histone deacetylase (HDAC) inhibitor and possible cognitive enhancer.[1][2][3] It potently inhibits the class I HDAC1, HDAC2, and HDAC3, with IC50 values of 39 nM, 41 nM, and 100 nM, respectively, whereas other HDACs were not assessed.[2] The drug has been found to potently promote synaptogenesis in vitro.[2][3] Synapsinostat was first described in the scientific literature by 2009.[1][2] Subsequently, other improved analogues acting as HDAC inhibitors such as crebinostat and neurinostat, which show much greater potency, were described.[4]
See also
References
- ↑ 1.0 1.1 "Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum". Journal of Medicinal Chemistry 52 (8): 2185–2187. April 2009. doi:10.1021/jm801654y. PMID 19317450.
- ↑ 2.0 2.1 2.2 2.3 "Synapse microarray identification of small molecules that enhance synaptogenesis". Nature Communications 2. October 2011. doi:10.1038/ncomms1518. PMID 22027590. Bibcode: 2011NatCo...2..510S. "Table 2 IC50 value (nM) of compounds toward specific HDACs tested in this study. [...]".
- ↑ 3.0 3.1 "Epigenetic mechanisms in mood disorders: targeting neuroplasticity". Neuroscience 264: 112–130. April 2014. doi:10.1016/j.neuroscience.2013.01.041. PMID 23376737. "Using a high-throughput, microfluidics-based, synapse microarray technology, Shi and colleagues recently described the identification of novel inducers of synaptogenesis, such as the potent HDAC inhibitor named ‘synapsinostat’ (Shi et al., 2011). Additionally, aiming to selectively target epigenetic mechanisms involved in CREB-mediated transcription, Fass and colleagues reported on the results of a high-throughput screen that led to the identification of another highly potent, and brain penetrant HDAC inhibitor named ‘crebinostat’ that regulated CREB-mediated transcription, enhanced synaptogenesis, and enhanced cognition in mice as assessed using contextual fear conditioning (Fass et al., 2013).".
- ↑ "Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity". Neuropharmacology 64: 81–96. January 2013. doi:10.1016/j.neuropharm.2012.06.043. PMID 22771460.
 |  |
